Home › Sistema ng Imunidad at mga Karamdaman
Pag-aaral pangklinika para sa Sistema ng Imunidad at mga Karamdaman na nagre-recruit sa U.S.
46 pag-aaral para sa Sistema ng Imunidad at mga Karamdaman ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Washington, DC13 pag-aaral
- New York City, NY12 pag-aaral
- Boston, MA10 pag-aaral
- Portland, OR10 pag-aaral
- Atlanta, GA10 pag-aaral
- Philadelphia, PA10 pag-aaral
- Houston, TX9 pag-aaral
- Los Angeles, CA9 pag-aaral
- Cleveland, OH8 pag-aaral
- Chicago, IL8 pag-aaral
- Seattle, WA6 pag-aaral
- Milwaukee, WI6 pag-aaral
- Tampa, FL6 pag-aaral
- Dallas, TX6 pag-aaral
- Cedar Rapids, IA6 pag-aaral
- Baldwin Park, CA5 pag-aaral
- Salt Lake City, UT5 pag-aaral
- Durham, NC5 pag-aaral
- Nashville, TN5 pag-aaral
- Pittsburgh, PA4 pag-aaral
- Phoenix, AZ4 pag-aaral
- Clifton, NJ4 pag-aaral
- Orlando, FL4 pag-aaral
- San Diego, CA4 pag-aaral
- St. Louis, MO4 pag-aaral
- Indianapolis, IN4 pag-aaral
- Omaha, NE3 pag-aaral
- Rochester, MN3 pag-aaral
- Buffalo, NY3 pag-aaral
- Denver, CO3 pag-aaral
- Fargo, ND3 pag-aaral
- Miami, FL3 pag-aaral
- Lewisville, TX3 pag-aaral
- Mountain View, CA3 pag-aaral
- Greenville, NC3 pag-aaral
- Richmond, VA3 pag-aaral
- Columbus, OH3 pag-aaral
- San Francisco, CA3 pag-aaral
- New Haven, CT3 pag-aaral
- Cincinnati, OH3 pag-aaral
Ayos sa estado
- Arizona5 pag-aaral
- Arkansas4 pag-aaral
- California19 pag-aaral
- Colorado5 pag-aaral
- Connecticut3 pag-aaral
- District of Columbia3 pag-aaral
- Florida13 pag-aaral
- Georgia13 pag-aaral
- Illinois10 pag-aaral
- Indiana4 pag-aaral
- Iowa6 pag-aaral
- Kentucky4 pag-aaral
- Maryland14 pag-aaral
- Massachusetts10 pag-aaral
- Michigan5 pag-aaral
- Minnesota4 pag-aaral
- Missouri6 pag-aaral
- Nebraska3 pag-aaral
- New Jersey6 pag-aaral
- New York15 pag-aaral
- North Carolina8 pag-aaral
- North Dakota3 pag-aaral
- Ohio9 pag-aaral
- Oregon10 pag-aaral
- Pennsylvania13 pag-aaral
- South Carolina3 pag-aaral
- Tennessee6 pag-aaral
- Texas17 pag-aaral
- Utah5 pag-aaral
- Virginia7 pag-aaral
- Washington7 pag-aaral
- Wisconsin6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Nagre-recruitPhase 2
Edad 4 hanggang 69 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04339777Genetic Analysis of Immune Disorders
Nagre-recruitObservasyonal na pag-aaral
1 Day – 101 Years · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00001467A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07765888Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Month – 99 Years · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00794352Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Month – 120 Years · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00006150Detection and Characterization of Infections and Infection Susceptibility
Nagre-recruitObservasyonal na pag-aaral
1 Month – 100 Years · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00404560A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07783425Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 4 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT02579967Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT04242095A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06722235A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07902817A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07541287A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06948318Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 7 hanggang 100 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT01568697Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07885605BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT05341726A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT04422912CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT03328078A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07192471Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Nagre-recruitObservasyonal na pag-aaral
Edad 1 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00001406METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Nagre-recruitPhase 2
Edad 18 hanggang 69 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07699380(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875PS-002 for the Treatment of IgA Nephropathy in Adults
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07182227A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07075185Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.